Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000874015-04-000085
Filing Date
2004-12-21
Accepted
2004-12-21 18:41:39
Documents
1
Period of Report
2004-12-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3965
  Complete submission text file 0000874015-04-000085.txt   5752
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ISIS PHARMACEUTICALS, INC. 2292 FARADAY AVENUE CARLSBAD CA 92008
Business Address 760-931-9200
Treble Michael J (Reporting) CIK: 0001311748 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19125 | Film No.: 041218740